Angiotensin II receptor subtypes.

  title={Angiotensin II receptor subtypes.},
  author={Pieter B.M.W.M. Timmermans and Andrew T. Chiu and William F. Herblin and Pancras C Wong and Ronald D. Smith},
  journal={American journal of hypertension},
  volume={5 6 Pt 1},
The octapeptide, angiotensin II (Ang II), the biologically active component of the renin-angiotensin system, elicits its multiple actions through the stimulation of specific surface receptors on various target organs. Although the existence of Ang II receptor subtypes has been suspected for some time, definitive evidence for Ang II receptor heterogeneity has been obtained only with the recently introduced nonpeptide Ang II receptor antagonists, exemplified by the prototypic compounds DuP 753… 
Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system.
A-II receptor antagonism appears to be as effective as ACE inhibition in the treatment of hypertension and other pathologic processes that involve the RAS and may offer an alternative to those patients who cannot tolerate ACE inhibitors because of their side effects.
Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular Pharmacotherapy
Clinical studies confirm the AII antagonist action ofLosartan and suggest that losartan will be effective in the treatment of essential HTN, and the utility of AII antagonism may extend beyond that of HTN and CHF, as suggested by the potential usefulness of angiotensin‐converting enzyme inhibition.
Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus
ACE, Ang II, and AT1 as well as AT2 receptor subtypes are present in the mouse hypothalamus and these data are the basis for further studies on the mouse brain Ang II system.
Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors.
The nuclear Ang-II-binding site in purified nuclei preparation from rat liver is characterized and it is shown to consist of soluble protein releasable from nuclei by freezing and thawing, hence distinct in physicochemical properties from the membrane-bound receptor.
Medicinal Chemistry of Angiotensin II Antagonists
The renin—angiotensin system (RAS) has been demonstrated to be a key element in blood pressure regulation and sodium balance.1 The therapeutic and commercial success of angiotensin-converting enzyme
Angiotensin II receptor pharmacology and AT1-receptor blockers
In neuronal cell lines, the AT2 receptor reportedly exerts antiproliferative effects and promotes neurite outgrowth, an effect accompanied by significant changes in the gene expression pattern of growth- and differentiation-related genes.
Angiotensin II receptor inhibition. A new therapeutic principle.
It seems likely that the angiotensin receptor antagonists will be added to the list of drugs that have been deemed suitable for first-line therapy in the treatment of hypertension and congestive heart failure.
Important roles for angiotensin III and IV in the brain renin-angiotensin system
The well-studied functions of the brain renin-angiotensin system are reviewed, including electrophysiological activation, tachyphylaxis, long term potentiation, learning and memory, and cognitive affect.
The past, present and future of angiotensin II type 2 receptor stimulation
An overview of the first results obtained by direct AT2 receptor stimulation with Compound 21, comprising effects on alkaline secretion, neurite outgrowth, blood pressure and post-infarct cardiac function.